top
Search terms
Results 1 - 10 of 13 - ordered by :
Pages: 1 2
Ehjcardiovascrec

Subjects with diabetes mellitus are at increased cardiovascular disease (CVD) risk.1 Particularly, diabetic patients with additional risk factors or target organ damage are considered as risk ...

Cardiovascular Research, Tousoulis, Dimitris

Date : 01/02/2019
ESC365

Optimal management of long term cardiovascular risk in diabetic patients with established coronary artery disease: a clinical case study.

Date : 26/08/2018
ESC365

Association between anti-diabetic treatment strategy and cardiovascular risk in diabetic patients with and without coronary artery disease

Date : 29/08/2017
Ehjcvp

[...]SGLT2 inhibition represents a novel treatment, which might be a promising target not only to (further) reduce blood glucose but also to target other cardiovascular risk factors. SGLT2 ...

European Heart Journal - Cardiovascular Pharmacotherapy, Review, Anne E. de Leeuw, Rudolf A. de Boer

Date : 01/10/2016 Item size : 586778 bytes
Ehjcvp

[...]SGLT2 inhibition represents a novel treatment, which might be a promising target not only to (further) reduce blood glucose but also to target other cardiovascular risk factors. SGLT2 ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEW, Anne E. de Leeuw, Rudolf A. de Boer

Date : 18/04/2016 Item size : 590679 bytes
Escardio

ECG-LVH results from the ROADMAP-study Roland SCHMIEDER (Erlangen, DE) 14:00 P4255 Clinical impact on target achievement and complications of intensified glucose control on top of metformin: ...

Poster Session 5: Diabetes: treatment and clinical implications

Date : 02/09/2013 Item size : 117879 bytes
Escardio

14:00 P295 Improved blood pressure profiles after regular aerobic exercise training in patients with arterial hypertension F van Buuren (Bad Oeynhausen, DE) 14:00 P296 Impact of fitness on total ...

Poster session 2

Date : 15/04/2011 Item size : 739746 bytes
Ehjournal

[...]interest has focused on CETP inhibition to augment current lipid-lowering strategies. In light of the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events ...

European Heart Journal, Lange, Richard A., Lindsey, Merry L.

Date : 01/11/2008 Item size : 133775 bytes
Ehjournal

[...]interest has focused on CETP inhibition to augment current lipid-lowering strategies. In light of the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events ...

European Heart Journal, Lange, Richard A., Lindsey, Merry L.

Date : 01/11/2008 Item size : 126508 bytes
Ehjournal

Adiponectin is an adipocytokine, which is mainly expressed in adipose tissue and has been identified as a potent insulin-sensitzing hormone.1 Adiponectin administration lowers glucose levels and ...

European Heart Journal, Kintscher, Ulrich

Date : 01/07/2007 Item size : 135455 bytes